Hae L. Lee

Seoul St. Mary's Hospital
Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma.

Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma.

Journal: Radiology
Published: August 04, 2026

Stereotactic body radiation therapy for hepatocellular carcinoma: 2026 expert consensus-based practical recommendation of the Korean Liver Cancer Association.

Stereotactic body radiation therapy for hepatocellular carcinoma: 2026 expert consensus-based practical recommendation of the Korean Liver Cancer Association.

Journal: Journal of liver cancer
Published: July 09, 2026

Toward a future role for liver biopsy in HCC: literature evidence and survey-based perspectives from Korean experts.

Toward a future role for liver biopsy in HCC: literature evidence and survey-based perspectives from Korean experts.

Journal: Journal of liver cancer
Published: May 04, 2026

Regorafenib as Second-Line Versus Later-Line Therapy in Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study with Exploratory Analysis of Prior Immune Checkpoint Inhibitor Exposure.

Regorafenib as Second-Line Versus Later-Line Therapy in Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study with Exploratory Analysis of Prior Immune Checkpoint Inhibitor Exposure.

Journal: Targeted oncology
Published: April 18, 2026

The Dynamic Nature of Renal Failure in Acute-on-Chronic Liver Failure: Sequence Matters.

The Dynamic Nature of Renal Failure in Acute-on-Chronic Liver Failure: Sequence Matters.

Journal: Gut and liver
Published: April 07, 2026

Moving beyond Ultrasound for Hepatocellular Carcinoma Surveillance in High-Risk Patients with Chronic Hepatitis B.

Moving beyond Ultrasound for Hepatocellular Carcinoma Surveillance in High-Risk Patients with Chronic Hepatitis B.

Journal: Gut and liver
Published: March 16, 2026

Varices and Hemorrhagic Events during Atezolizumab-bevacizumab Treatment: Reassurance with Caveats for Prognosis.

Varices and Hemorrhagic Events during Atezolizumab-bevacizumab Treatment: Reassurance with Caveats for Prognosis.

Journal: Gut and liver
Published: March 06, 2026

Machine learning based hepatic safety score predicts decompensation in hepatocellular carcinoma systemic therapy.

Machine learning based hepatic safety score predicts decompensation in hepatocellular carcinoma systemic therapy.

Journal: NPJ digital medicine
Published: October 25, 2025

Enhanced pathogen detection and gut microbiome alterations in pyogenic liver abscess: insights from next-generation sequencing.

Enhanced pathogen detection and gut microbiome alterations in pyogenic liver abscess: insights from next-generation sequencing.

Journal: Gut pathogens
Published: October 12, 2025

Liver Stiffness Measured by Vibration-Controlled Transient Elastography Predicts Hepatic Decompensation in Patients with Hepatocellular Carcinoma Receiving Systemic Treatments.

Liver Stiffness Measured by Vibration-Controlled Transient Elastography Predicts Hepatic Decompensation in Patients with Hepatocellular Carcinoma Receiving Systemic Treatments.

Journal: Liver cancer
Published: September 10, 2025

Challenges of an EMR-Based Hospital Alert Program for Micro-Elimination of Hepatitis C in Tertiary Referral Hospitals.

Challenges of an EMR-Based Hospital Alert Program for Micro-Elimination of Hepatitis C in Tertiary Referral Hospitals.

Journal: Journal of viral hepatitis
Published: September 09, 2025

Besifovir dipivoxil maleate versus other antivirals in reducing hepatocellular carcinoma in chronic hepatitis B.

Besifovir dipivoxil maleate versus other antivirals in reducing hepatocellular carcinoma in chronic hepatitis B.

Journal: Scientific reports
Published: May 03, 2025
Showing 1-12 of 56

Last Updated: 09/26/2026